All News

2020

July

Media Release / Jul 01, 2020

Sandoz reviewing options after Federal Circuit upholds lower court ruling in biosimilar Erelzi® case

Read More

June

Media Release / Jun 19, 2020

Novartis discontinues hydroxychloroquine clinical trial based on slow enrollment, remains committed to pandemic research efforts

Read More
Media Release / Jun 04, 2020

Sandoz launches once-daily generic tacrolimus for transplant patients in Europe

Read More

April

Media Release / Apr 28, 2020

Novartis maintains strong operational performance in Q1, confirms FY 2020 guidance at this time, and advances a broad range of efforts to support the global response to COVID-19

Read More
Media Release / Apr 20, 2020

Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients

Read More
Media Release / Apr 02, 2020

Novartis announces mutual agreement to terminate sale of Sandoz US generic oral solids, dermatology portfolio to Aurobindo

Read More

March

Media Release / Mar 30, 2020

Novartis donation: Consignment of 30 million hydroxychloroquine tablets ships to US Department of Health and Human Services

Read More
Media Release / Mar 25, 2020

Sandoz announces new country head for Japan

Read More
Media Release / Mar 20, 2020

Novartis commits to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response

Read More
Media Release / Mar 02, 2020

Sandoz Resolves Generic Drug Antitrust Investigation in the U.S.

Read More